IGC Pharma shareholders approve 4x increase in authorized shares to 600M and 5M share grant

IGC Pharma, Inc.

Shareholders approved amendment to increase authorized common stock from 150M to 600M shares.
Approved grant of up to 5M shares for employees, advisors, directors, and consultants under performance metrics.
Re-elected directors Ram Mukunda and James Moran as Class C directors until 2028.
Ratified Manohar Chowdhry & Associates as independent auditor for fiscal 2026.
Non-binding advisory vote set frequency of executive compensation votes every three years.

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.